대시보드포트폴리오관심 목록커뮤니티발견스크리너
NOT FOR DISTRIBUTION

Aspen Aerogels, Inc.

NYSE:ASPN 주식 리포트

시가총액: US$425.7m

  • 회사 개요
    • 가치 평가
    • 미래 성장
    • 과거 실적
    • 재무 건전성
    • 배당
  • 경영진
  • 지분
  • 기타 정보
  • 주식 커뮤니티

Aspen Aerogels 경영진

경영진 기준 점검 3/4

Aspen Aerogels CEO는 Don Young, Nov2001 에 임명되었습니다 의 임기는 24.83 년입니다. 총 연간 보상은 $2.69M, 21.5% 급여 및 78.5% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $2.25M 가치에 해당하는 회사 주식의 0.53% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 1 년과 8.2 년입니다.

핵심 정보

Don Young

최고경영자

US$2.7m

총 보수

CEO 급여 비율21.49%
CEO 재임 기간24.8yrs
CEO 지분 보유율0.5%
경영진 평균 재임 기간1yr
이사회 평균 재임 기간8.2yrs

최근 경영진 업데이트

Recent updates

User avatar
내러티브 업데이트 • Sep 05

ASPN: Q2 Beat And EBITDA Turn Will Test Execution And Profitability

Analysts recently lifted their price targets on Aspen Aerogels to a range between $5 and $9, reflecting updated views on fair value after the company reported a solid Q2 beat, guided to a return to positive adjusted EBITDA, and noted what they describe as improved visibility across both operating segments. Analyst Commentary Recent research on Aspen Aerogels highlights a mixed tone.
User avatar
내러티브 업데이트 • Aug 22

ASPN: Positive EBITDA Guidance And Q2 Execution Will Support Future Upside

Analysts have lifted their fair value estimate for Aspen Aerogels from $8.00 to $10.00 after recent price target increases that they link to a solid Q2 performance, a return to positive adjusted EBITDA guidance, and what they describe as better visibility across the company’s segments. Analyst Commentary Recent commentary around Aspen Aerogels has centered on fresh price target increases that reflect how analysts are interpreting the latest Q2 report.
Seeking Alpha • Aug 10

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Summary Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science. But…. Aspen Aerogels is an example of why we should look beyond chicness. It has a simple and recently depressed business selling high performance protective barriers. They’re vital for EV batteries, to prevent heat from spreading and leading to explosions. They’re also useful for LNG transmission. EVs demand is starting to recover. That’s good. Better still…. Materials keep evolving and new uses surface. ASPN is preparing to adapt its wares to data centers, grid overhaul, and lots more. That makes the stock a speculative “Buy.”. Read the full article on Seeking Alpha
User avatar
내러티브 업데이트 • Aug 08

ASPN: Improved Segment Visibility And Restart Progress May Support Future Upside

Analysts have lifted the fair value estimate for Aspen Aerogels from $6.35 to $7.55, citing higher modeled revenue growth, a slightly stronger long term profit margin profile, and recent Street research pointing to better visibility across both operating segments after the latest quarterly updates. Analyst Commentary Recent Street research on Aspen Aerogels points to higher conviction around the company’s outlook following the latest quarterly update.
User avatar
내러티브 업데이트 • Jul 14

ASPN: Explosion Disruption And Weaker Margins Will Pressure Shares

Aspen Aerogels’ analyst price target has been raised by $1 as analysts point to updated assumptions around fair value, revenue growth, profit margins, discount rate and future P/E to support the change. What's in the News for Aspen Aerogels Aspen Aerogels reported an explosion at its East Providence, Rhode Island manufacturing facility on April 8, 2026.
User avatar
내러티브 업데이트 • Jun 30

ASPN: Cost Controls And Facility Restart Will Support Future Upside

Analysts have lifted their fair value estimate for Aspen Aerogels to $8.00 from $6.00, citing updated assumptions around revenue growth, profit margins, discount rates and future P/E expectations as reflected in recent Street research, including the latest $1 price target increase from Barclays. What's in the News Aspen Aerogels reported that an explosion occurred at its East Providence, Rhode Island manufacturing facility on April 8, 2026, damaging a portion of the production space and leading to a temporary halt of operations, with an investigation into the cause ongoing.
User avatar
내러티브 업데이트 • Jun 16

ASPN: Fair Outlook As Restart Progress And Refinements Shape Future Stock Performance

Analysts have lifted their Aspen Aerogels price target by $1, citing updated assumptions around discount rates, profit margins and future P/E that refine rather than overhaul their prior valuation work. What’s in the News for Aspen Aerogels Aspen Aerogels began a staged restart of manufacturing operations at its East Providence, Rhode Island facility after completing mechanical, operational, and safety reviews in coordination with local, state, and federal agencies.
User avatar
내러티브 업데이트 • Jun 02

ASPN: Fair Outlook Balances Facility Setback With Long-Term Opportunity

Analysts have adjusted their outlook on Aspen Aerogels with a modestly lower price target, citing updated views on growth, profitability, and valuation following recent Street research moves that included a $1 reduction and a separate $1 increase in targets at $3 and $4. Analyst Commentary Recent research on Aspen Aerogels reflects a mix of caution and selective optimism, centered on updated views of growth, execution, and valuation following the latest price target changes.
User avatar
내러티브 업데이트 • Apr 30

ASPN: GM Demand Reset And Facility Disruption Will Pressure Shares

Analysts have cut Aspen Aerogels' price targets into a lower $3 to $6 range, citing Q4 and Q1 misses, GM related EV demand weakness, and a tough near term outlook, partially balanced by cost actions, a growing net cash position, and what they see as longer term platform value. Analyst Commentary Recent Street research highlights that several bearish analysts have reset expectations lower for Aspen Aerogels, trimming price targets into a $3 to $6 range after the Q4 earnings miss and a soft Q1 outlook.
User avatar
내러티브 업데이트 • Apr 15

ASPN: GM Demand Reset And Tough Outlook Will Pressure Shares

Analysts have cut their average price targets on Aspen Aerogels to a range of about $3 to $6. This reflects weaker near term expectations tied to GM related EV softness, offset by company efforts to protect cash, reduce costs, and focus on longer term platform value.
User avatar
내러티브 업데이트 • Apr 01

ASPN: Cost Discipline And GM Settlement Cash Will Support Future Upside

Analysts have reduced their average price targets on Aspen Aerogels to a range of about $3 to $6, citing Q4 earnings and guidance shortfalls, ongoing softness tied to GM and the broader EV reset, as well as a sharper company focus on cash preservation and cost controls. Analyst Commentary Across recent research notes, analysts broadly cut price targets on Aspen Aerogels following Q4 results and softer guidance, but the tone is mixed rather than uniformly negative.
User avatar
내러티브 업데이트 • Mar 18

ASPN: Cost Actions And Cash Support Will Drive Long-Term Upside Potential

Analysts have reduced the fair value estimate for Aspen Aerogels from $10 to $6, reflecting lower price targets across the Street as they weigh weaker GM related EV demand against the company's cost actions, cash support from the GM settlement, and longer term platform potential. Analyst Commentary Street research has shifted sharply lower on headline price targets, but the tone is not uniformly negative.
User avatar
내러티브 업데이트 • Mar 04

ASPN: Tough Year And GM Demand Reset Will Pressure Shares

Narrative Update: Aspen Aerogels The analyst price target for Aspen Aerogels has moved from $6.00 to $3.00 as analysts factor in a tough year following a Q4 earnings miss and softer guidance, partly offset by cost actions and a stronger net cash position tied to the GM settlement. Analyst Commentary Bearish analysts have reset expectations for Aspen Aerogels, cutting price targets across the board after the Q4 earnings miss and softer near term guidance.
User avatar
내러티브 업데이트 • Feb 18

ASPN: Updated Profitability Assumptions Will Still Support Long-Term Upside Potential

Analysts have lifted their price target for Aspen Aerogels to $10.00, citing updated inputs around revenue growth, profit margins, and future P/E assumptions as the key drivers of this change. Valuation Changes Fair Value: revised slightly from $9.98 to $10.00 per share, aligning with the updated price target.
User avatar
내러티브 업데이트 • Feb 04

ASPN: Higher 2025 Loss Guidance Will Still Support Long-Term Opportunity

Analysts have adjusted their price target on Aspen Aerogels, highlighting a slightly higher discount rate and future P/E assumptions, along with modest tweaks to revenue growth and profit margin expectations, as they reassess the risk and earnings profile embedded in their valuation models. What's in the News Aspen Aerogels revised full year 2025 revenue guidance to a range of $270 million to $280 million, compared with prior guidance of $297 million to $317 million (company guidance).
분석 기사 • Jan 23

Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge Not Quite Adding Up

Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 32% in the...
User avatar
내러티브 업데이트 • Jan 20

ASPN: Lower 2025 Guidance Will Still Support Long-Term Upside Potential

Analysts have raised their price targets on Aspen Aerogels, citing updated assumptions for the discount rate, revenue growth, profit margin, and future P/E that together suggest a modest improvement in their overall outlook for the shares. What's in the News Aspen Aerogels revised its full-year 2025 revenue guidance to a range of US$270 million to US$280 million, compared with prior guidance of US$297 million to US$317 million (company guidance).
User avatar
내러티브 업데이트 • Jan 06

ASPN: Lower 2025 Outlook Will Still Support Attractive Long-Term Upside Potential

Analysts have lifted their price target on Aspen Aerogels to reflect updated assumptions around revenue growth, profit margins, discount rate and future P/E. The new target implies a valuation aligned with these revised inputs compared with the prior figure.
User avatar
내러티브 업데이트 • Dec 19

ASPN: Reduced Guidance And Higher Discount Rate Will Present Long-Term Upside Opportunity

Aspen Aerogels' consensus analyst price target has been reduced by approximately $4.02 per share, as analysts temper their assumptions for revenue growth and profit margins, while also applying a slightly higher discount rate and multiple to future earnings. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from prior expectations of $297 million to $317 million (Key Developments).
User avatar
내러티브 업데이트 • Dec 05

ASPN: Improving Risk Profile Will Support Long-Term Opportunity Despite Wider Losses

Analysts have raised their price target on Aspen Aerogels by a modest amount, now embedding slightly lower discount rates and marginally softer future valuation multiples, as they emphasize the company’s improving risk profile and steady long term growth outlook. What's in the News Aspen Aerogels lowered its full year 2025 revenue guidance to a range of $270 million to $280 million, down from the prior outlook of $297 million to $317 million (company guidance).
분석 기사 • Dec 04

Aspen Aerogels (NYSE:ASPN) Might Have The Makings Of A Multi-Bagger

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
User avatar
내러티브 업데이트 • Nov 21

ASPN: Lower Profit Margins Will Drive Opportunity As Net Losses Peak

Analysts have lowered their price target for Aspen Aerogels from $8.75 to $6.83 per share. They cite revised expectations for slower revenue growth and profit margins.
User avatar
내러티브 업데이트 • Nov 07

ASPN: Reduced EV Tax Credits Will Challenge Thermal Segment Performance Ahead

Analysts have lowered their price target for Aspen Aerogels from $9.58 to $8.75. They cited reduced electric vehicle production forecasts and increased macroeconomic pressures on the company’s key Thermal Barrier business segment.
분석 기사 • Oct 11

Optimistic Investors Push Aspen Aerogels, Inc. (NYSE:ASPN) Shares Up 27% But Growth Is Lacking

Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a really impressive month, gaining 27% after a shaky period...
분석 기사 • Aug 09

Aspen Aerogels, Inc. (NYSE:ASPN) Analysts Are Pretty Bullish On The Stock After Recent Results

NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...
User avatar
내러티브 업데이트 • Aug 08

Cost Optimization And Industrial Demand Will Shape Future Markets

The consensus price target for Aspen Aerogels has increased, reflecting a higher valuation multiple (future P/E rising from 14.46x to 20.08x) despite a notable decline in net profit margin (from 14.47% to 11.75%), resulting in a new fair value estimate of $9.75. What's in the News Ricardo Rodriguez will step down as CFO at the end of Q3 and be succeeded by Grant Thoele, who currently serves as Chief of Staff and VP of Corporate Strategy and Finance.
분석 기사 • Aug 06

Aspen Aerogels, Inc.'s (NYSE:ASPN) Shares Climb 28% But Its Business Is Yet to Catch Up

NYSE:ASPN 1 Year Share Price vs Fair Value Explore Aspen Aerogels's Fair Values from the Community and select yours...
분석 기사 • Jul 09

Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
분석 기사 • Jun 11

Aspen Aerogels, Inc.'s (NYSE:ASPN) 29% Share Price Surge Not Quite Adding Up

Those holding Aspen Aerogels, Inc. ( NYSE:ASPN ) shares would be relieved that the share price has rebounded 29% in the...
분석 기사 • Apr 17

Not Many Are Piling Into Aspen Aerogels, Inc. (NYSE:ASPN) Stock Yet As It Plummets 30%

To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 30% in the...
분석 기사 • Apr 01

Aspen Aerogels (NYSE:ASPN) Has A Pretty Healthy Balance Sheet

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Seeking Alpha • Mar 31

Aspen Aerogels: Tariffs, Tesla And The Silver Lining

Summary Aspen Aerogels' growth is tied to the EV market, which faces uncertainty due to the potential elimination of the EV tax credit. Despite fears, Aspen Aerogels may benefit from Tesla's declining market share, as smaller EV players gain traction, particularly in Europe and China. US EV sales are expected to plateau until 2027, potentially limiting Aspen's revenue growth. But international markets offer expansion opportunities. The market may be overreacting to Aspen's stock decline. The company's prospects remain strong with increasing production capabilities in non-US markets. Read the full article on Seeking Alpha
분석 기사 • Feb 28

Positive Sentiment Still Eludes Aspen Aerogels, Inc. (NYSE:ASPN) Following 34% Share Price Slump

To the annoyance of some shareholders, Aspen Aerogels, Inc. ( NYSE:ASPN ) shares are down a considerable 34% in the...
Seeking Alpha • Feb 14

Aspen Aerogels: Insulation Play Leaves Investors In The Cold

Summary Aspen Aerogels has seen significant revenue growth from EV insulation but faces challenges with EV demand, tariffs, and potential oversupply. Despite impressive revenue increases, shares have fallen due to concerns over market demand and halted construction of a new plant. The company reported strong 2024 sales and profits but faces a slowdown in EV revenue growth, with 2025 becoming a much tougher year. Given the uncertain outlook and recent setbacks, I remain cautious about ASPN stock but see the potential appeal if incremental improvements materialize throughout 2024. Read the full article on Seeking Alpha
분석 기사 • Feb 14

Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Seeking Alpha • Dec 23

Aspen Aerogels: There Are Reasons To Be Careful But It's So Cheap

Summary The company has recently taken on significant debt to finance its Statesboro plant. Stock were issued to improve the balance. The market didn't like but could make sense if it's compensated with growth thanks to the new Statesboro Plant. Q3 2024 earnings showed 92.93% YoY revenue growth and improved margins, but flat quarter-over-quarter sales led to a 28% stock decline. It's currently trading at 12 times forward EV/EBITDA and only 2.5 EV/Sales despite its revenue growth of almost 90%, so I think it's cheap. Read the full article on Seeking Alpha
Seeking Alpha • Dec 02

Aspen Aerogels: Thermal Barriers Could Sustain Further Growth Despite A Chilly Market

Summary I find Aspen's 93% YoY revenue growth in Q3 2024 quite impressive, driven entirely by organic demand for PyroThin thermal barriers, with revenue guidance raised significantly this year. Gross margins climbed to 42% in the past quarter, while adj. EBITDA is projected to reach $90M in FY2024. Management's debt refinancing decision reduces dilution risks in the long term, a move I highly favor, despite the recent public offering. I foresee strong long-term growth from the Statesboro facility, set to generate $1.2–$1.6B annually, once completed in 2026. While potential changes to EV tax credits in the US and customer concentration pose risks, I believe Aspen's strong fundamentals and long-term growth drivers justify my cautious buy rating. Read the full article on Seeking Alpha
Seeking Alpha • Nov 17

Aspen Aerogels: Despite Recent Pressure, This Is Intriguing

Summary Aspen Aerogels has transformed from an industrial insulation supplier to a key EV sector player, showing significant revenue growth and operating leverage. Despite impressive results and DOE funding news, shares fell due to a low-priced equity issue, concerns over EV demand, and uncertainty about a new factory. Shares dropped nearly 50% in a month, with third quarter sales up 93% YoY, driven by thermal barrier revenues, while facing capacity constraints. The company's valuation appears modest, with potential upside from the new factory and DOE loan, despite political and inflationary risks. Read the full article on Seeking Alpha
분석 기사 • Nov 07

With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For

Aspen Aerogels, Inc. ( NYSE:ASPN ) shares have had a horrible month, losing 32% after a relatively good period...
Seeking Alpha • Oct 28

Aspen Aerogels: Interesting Times

Summary Aspen Aerogels has transformed from an insulation supplier to a key player in the EV sector, showing strong revenue growth and operating leverage. Despite impressive quarterly results and preliminary DOE funding for a new plant, concerns about EV demand remain. The company raised $85 million through a share issuance, despite holding over $100 million in cash, raising questions about future funding needs. At around $20 per share, I see potential in Aspen Aerogels, despite recent share dilution and lack of sequential growth in Q3. Read the full article on Seeking Alpha
분석 기사 • Oct 17

Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

CEO 보수 분석

Don Young의 보수는 Aspen Aerogels의 수익에 비해 어떻게 변했나요?
날짜총 보수급여회사 수익
Jun 30 2026n/an/a

-US$126m

Mar 31 2026n/an/a

-US$112m

Dec 31 2025US$3mUS$577k

-US$390m

Sep 30 2025n/an/a

-US$305m

Jun 30 2025n/an/a

-US$312m

Mar 31 2025n/an/a

-US$286m

Dec 31 2024US$3mUS$515k

US$13m

Sep 30 2024n/an/a

US$1m

Jun 30 2024n/an/a

US$1m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$4mUS$515k

-US$46m

Sep 30 2023n/an/a

-US$55m

Jun 30 2023n/an/a

-US$71m

Mar 31 2023n/an/a

-US$80m

Dec 31 2022US$2mUS$515k

-US$83m

Sep 30 2022n/an/a

-US$89m

Jun 30 2022n/an/a

-US$68m

Mar 31 2022n/an/a

-US$50m

Dec 31 2021US$8mUS$511k

-US$37m

Sep 30 2021n/an/a

-US$27m

Jun 30 2021n/an/a

-US$26m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020US$2mUS$496k

-US$22m

Sep 30 2020n/an/a

-US$17m

Jun 30 2020n/an/a

-US$12m

Mar 31 2020n/an/a

-US$12m

Dec 31 2019US$2mUS$515k

-US$15m

보상 대 시장: Don의 총 보수(USD2.69M)는 US 시장에서 비슷한 규모 기업의 평균(USD2.43M) 수준입니다.

보상과 수익: Don의 보상은 지난 1년 동안 회사 실적과 일치했습니다.


CEO

Don Young (69 yo)

24.8yrs
재임 기간
US$2,685,085
보수

Mr. Donald R. Young, also known as Don, has been the President, Chief Executive Officer and Director of Aspen Aerogels, Inc. since November 2001. Mr. Young possesses specific attributes that qualify him to...


리더십 팀

이름직위재임 기간보수지분
Donald Young
President24.8yrsUS$2.69m0.53%
$ 2.2m
Grant Thoele
CFO, Treasurer & Principal Financial and Accounting Officerless than a yearUS$943.34k0.012%
$ 51.9k
Gregg Landes
Chief Operating Officer6.9yrsUS$1.38m0.032%
$ 135.0k
Glenn Deegan
Chief Administrative Officer1yrUS$750.52k데이터 없음
Corby Whitaker
Chief Commercial Officerless than a yearUS$1.44m0.15%
$ 657.5k
Neal Baranosky
Senior Director of Corporate of Strategy & Financeno data데이터 없음데이터 없음
Paul Betts
Managing Director of Investment Banking at RBC Capital Markets Inc.no data데이터 없음데이터 없음
1.0yrs
평균 재임 기간
56yo
평균 나이

경험이 풍부한 관리: ASPN의 경영진은 경험이 부족한 것으로 간주됩니다(평균 재임 1 년) — 신규 팀일 수 있습니다.


이사회 구성원

이름직위재임 기간보수지분
Donald Young
President24.8yrsUS$2.69m0.53%
$ 2.2m
William Noglows
Independent Chairman12.3yrsUS$195.41k0.15%
$ 635.0k
James Sweetnam
Independent Director4.1yrsUS$147.50k0.031%
$ 133.1k
Steven Mitchell
Independent Director17.1yrsUS$140.00k0.18%
$ 751.7k
Kathleen Kool
Independent Director3.8yrsUS$159.16k0.029%
$ 122.9k
Cari Robinson
Independent Director2.1yrsUS$150.66k0.015%
$ 62.8k
8.2yrs
평균 재임 기간
65yo
평균 나이

경험이 풍부한 이사회: ASPN의 이사회는 경험이 있음으로 간주됩니다(평균 재임 8.2 년).


기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/09/18 01:14
종가2026/09/18 00:00
수익2026/06/30
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
  • SEC 양식 10-K
  • SEC 양식 10-Q
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
  • 분석가 리서치 보고서
  • Blue Matrix
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
  • ICE 시장 데이터
  • SEC 양식 S-1
지분 구조10년
  • 주요 주주
  • 내부자 거래
  • SEC 양식 4
  • SEC 양식 13D
경영진10년
  • 리더십 팀
  • 이사회
  • SEC 양식 10-K
  • SEC 양식 DEF 14A
주요 개발10년
  • 회사 공시
  • SEC 양식 8-K

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.

Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Aspen Aerogels, Inc.는 15명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Benjamin KalloBaird
J. David AndersonBarclays
Ryan PfingstB. Riley Securities, Inc.

어디서든 더 나은 투자 결정을 내리세요

스캔하여 다운로드
App Store 열기Google Play 열기
Chrome 웹 스토어
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
데이터 소스 보기
시장
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
투자 아이디어
  • 저평가 기업
  • 고배당 우량주
  • 임원 매수
  • 원자력 에너지
  • 자율주행차
  • 인공지능
  • 암호화폐 및 블록체인
  • 사이버보안
  • 더 많은 아이디어
주식 커뮤니티
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
기능 및 도구
  • 포트폴리오 추적기
  • 주식 스크리너 & 알림
  • 내러티브 및 적정 가치
  • 배당 계산기
뉴스 및 탐색
  • 최신 주식 뉴스
  • 글로벌 시장 인사이트
  • 더 폭스홀
  • 투자 아이디어
  • 커뮤니티 스토리
  • 새로운 소식
Simply Wall St
  • 플랜 및 가격
  • 광고
  • 회사 소개
  • 문의하기
  • 채용
  • 도움말 센터
  • 주식 투자 학습
  • 제휴 프로그램
  • 비즈니스 & 엔터프라이즈
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • 이용 약관
  • 개인정보처리방침
  • AI 약관
  • 금융 서비스 가이드